In atopic asthmatic patients, a placebo-controlled trial showed that the inhaled GATA-3-specific DNAzyme SB010 successfully attenuated allergen-induced sputum eosinophilia, and also decreased plasma levels of IL-5 [195]. The gene discussed is IL5; the disease is Increased total eosinophil count.